Chordate and Nanos Medical concludes Joint venture for China 2018-05-24

Press Release Chordate and Nanos Medical concludes Joint venture for China Kista-Shanghai, 24 May 2018. Chordate Medical Holding AB (publ) (“Chordate”) has, through its subsidiary Chordate Medical AB, signed an agreement of co-ownership of a newly registered Shanghai-based company in a Joint venture with Nanos Medical (Shanghai) Limited (‘ Nanos Medical ‘), primarily concerning the Chinese market. Nanos Medical invests MUSD 1.5 for about 67 […]

EUFOREA’s RHINOLOGY FUTURE DEBATES

Watch EUFOREA’s rhinology future debate held on 8th of December 2017. Chordate takes part in ‘Nasal turbinate as therapeutic target’ http://www.youtube.com/watch?time_continue=20&v=YHTE_zbgyDw/

Chordate enrolls first patients in a randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy of intranasal kinetic oscillation stimulation in the treatment of chronic non-allergic rhinitis 2018-05-08

Chordate enrolls first patients in a randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy of intranasal kinetic oscillation stimulation in the treatment of chronic non-allergic rhinitis Data Anticipated Q4 2019 Kista, Sweden, May 08, 2018 — Chordate Medical Holding AB’s (publ) (“Chordate”), a specialty medtech company that focuses on developing and commercializing neuromodulating treatment systems for treating non-allergic rhinitis and migraine, today announced that […]

Chordate enrolls first patient in a study to evaluate the efficacy of intranasal kinetic oscillation stimulation in the preventive treatment of chronic migraine 2018-03-23

Chordate enrolls first patient in a randomized, placebo-controlled, double-blind, multicenter study to evaluate the efficacy of intranasal kinetic oscillation stimulation in the preventive treatment of chronic migraine. Kista, Sweden, March 23, 2018 — Chordate Medical Holding AB’s (publ) (“Chordate”), a specialty medtech company that focuses on developing and commercializing neuromodulating treatment systems for treating non-allergic rhinitis and migraine, today announced that the first patient was […]

CHORDATE WILL PARTICIPATE IN EUROPEAN RHINOLOGIC SOCIETY MEETING 2018-03-21

Chordate Medical will participate in European Rhinologic Society Meeting (ERS) in London 22-26 April. http://www.erslondon2018.com/

CHORDATE AND STERIPOLAR EXHIBIT DURING ENT-CONGRESS 2018-02-08

Together with Steripolar, Chordate exhibits during the ENT-congress in Helsinki, Finland February 8-9.

CHORDATE SIGNS DISTRIBUTION AGREEMENT FOR FINLAND 2018-02-05

Chordate signs distribution agreement with Steripolar for Finland.

Chordate and Nanos Medical signs a Letter of Intent for a joint venture agreement regarding China 2017-12-18

Press Release Chordate and Nanos Medical signs a Letter of Intent for a joint venture agreement regarding China Kista-Shanghai, 18th December 2017. Chordate Medical Holding AB (publ.) (“Chordate”) has through its subsidiary Chordate Medical AB signed a letter of intent regarding a joint venture with Nanos Medical (Shanghai) Limited (” Nanos Medical “) mainly related to the Chinese market. Nanos Medical will own 67 percent […]

Chordate will attend the Rhinology Future Debate 2017-12-04

Chordate will be attending the Rhinology Future Debate organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) in Brussels 8th of December. EUFOREA brings together key opinion leaders in the field of respiratory diseases, industrial partners and patients in a forum on novel developments in the rhinology and the respiratory field. The Rhinology Future Debates is a clinician-orientated meeting […]

CHORDATE TAKES PART IN EUROPEAN RHINOLOGY RESEARCH FORUM 2017-11-07

Chordate will take part in European Rhinology Research Forum 2017. It will be held in Brussels, Belgium on 9-10 November organized by European Forum for Research and Education in Allergy and Airway diseases (EUFOREA) and the European Rhinologic Society (ERS).